Detailed IVF article
IN VITRO FERTILIZATION AND THE ASSISTED REPRODUCTIVE TECHNOLOGIES (ART)
The History of the Procedure
In Vitro Fertilization (IVF) was developed by a collaboration between Dr. Patrick Steptoe, a British gynecologist and Dr. Robert Edwards, a Ph.D. Dr. Steptoe was a pioneer in laparoscopy and had accumulated a group of patients who had absent fallopian tubes. Clearly the only way for them to conceive was to retrieve an egg, fertilize it in the lab, and then transfer the subsequent embryo into the uterus. Their early attempts were fraught with difficulties but none the less in 1978 they were successful with the delivery of Mary Louise Brown, "The World's First Test Tube Baby". Initially, In Vitro Fertilization was highly inefficient because of the use of the natural cycle and the ability to only retrieve one oocyte at a time. Also, the initial retrieval technique was by laparoscopy, which required a general anesthetic and a major surgical procedure to retrieve a single oocyte. By 1984, the first successful U. S. In Vitro Fertilization birth had occurred. From the mid 80's to the early 90's, the number of In Vitro Fertilization clinics increased dramatically in the United States. In the early 90's this number was reduced as it became clear that it required considerable training and experience to operate a successful In Vitro Fertilization Program.
IVF is simply the uniting of egg and sperm in vitro, (i.e. in the laboratory). Subsequently, the embryo is transferred into the uterus and pregnancy is allowed to begin. Initially, this technique was available to women with severe tubal disease only. With increased experience with this technique, it was found that it was an effective treatment for almost all forms of intractable infertility. Therefore, individuals with endometriosis, ovulation problems, unexplained infertility, or male factor infertility could be treated with this technique if simpler measures were not effective.
The starting point in the procedure is called superovulation. Superovulation involves the recruitment of multiple follicles, which are the structures within which the egg develops. Modern techniques of superovulation include many different hormone and drug combinations. The most typically used stimulatory agents are potent injectable drugs, such as Humegon, Repronex, Gonal-F or Follistim. The most common pre-treatment is with a medication known as Lupron. Lupron pre-treatment tends to allow for more parallel development of follicles so on the day of harvest more mature oocytes are available for pick up. Also, Lupron pre-treatment decreases the cancellation rate of the cycle due to premature ovulatory signals. Because of this, a combination of Lupron pre-treatment followed by a potent injectable drug such as Gonal-F or Follistim is probably the most popular worldwide for preparation for In Vitro Fertilization. Typically, in the month prior to the one intended to be used for oocyte harvest, Lupron is begun. Lupron injections are given subcutaneously until there is evidence of shutdown of the ovaries. Following this several days of an injectable agent, such a Gonal-F, is initiated.
After 8 to 9 days of injections the follicles are usually considered mature and human chorionic gonadotropin (hCG) is administered. hCG is literally a trigger for ovulation. It allows for final maturation of the oocytes. Thirty-six hours after the hCG is given, and immediately prior to ovulation, oocyte retrieval is planned.
Oocyte retrieval can be accomplished by a variety of different techniques. At the present time the worldwide consensus is that transvaginal retrieval is the least traumatic way of performing the procedure. This type of technique is also called a nonsurgical ultrasound guided retrieval. The technique relies heavily on the normal pelvic anatomy. It is well known that the ovaries are in very close proximity to the upper vagina. Using transvaginal retrieval an ultrasound probe is placed in the upper vagina and is used to guide a narrow gauged needle into the follicles. Typically this is done under light anesthesia. The patient does not have to be "put to sleep". An egg retrieval takes 30 minutes to complete. There is minimal or no discomfort associated with it. A typical number of eggs retrieved is 5-12. For some photos of the IVF retrieval area and embryo lab, please go to: IVF photo gallery.
Fertilization of the Egg
Following egg retrieval the husband is asked to do a sperm collection. The sperm is processed by a technique known as "washing". This is to remove any additional cellular material or chemical substances within the ejaculate. A pure suspension of sperm is then added to the eggs. Each egg is inseminated with 50,000-100,000 motile spermatozoa. If semen parameters are poor, direct Intracytoplasmic Sperm Injection (ICSI) is performed. ICSI has revolutionized IVF. We are now able to treat cases where only a few sperm are in the ejaculate. Also, we can collect sperm directly from the testes in cases where the sperm count is zero and use these for ICSI. ICSI has been used widely for 6 years in the U.S. Because ICSI involves the lab picking and injecting the sperm into the egg, the process of "natural selection" is eliminated. There were initial concerns that ICSI may increase the incidence of birth defects. The current information is that ICSI increases the incidence of birth defects by 0-1%. It will take more births to narrow the interval further. Most birth defects appear to be minor, correctable by plastic surgical procedures. IVF has been around since 1978 and we know that it does not increase the incidence of birth defects. Embryo freezing has been available since 1985 and it is known that freezing does not increase the incidence of birth defects. The overall incidence of birth defects in the general population is 3-5%.
The day following the retrieval we can examine the oocytes for evidence of fertilization. If there are an excess number of embryos, a decision can be made regarding cryopreservation or freezing. Generally speaking, in a woman under the age of 35, it would be considered appropriate to transfer up to 2-3 embryos. In women 35-40, each program generally individualizes based on their results. In our program we recommend the transfer of 3-5 embryos because we have noticed that the implantation rate is slightly lower. Transferring higher number of embryos would generally improve the pregnancy rate, but will also increase the multiple pregnancy rate.
Embryo transfer is much like a slowly conducted pelvic examination. A speculum is placed in the vagina. The vagina is cleansed with sponges. A premeasured catheter is then advanced to the very top of the uterus where the embryos are deposited in a very small droplet of fluid. Following embryo transfer, the patient will usually rest quietly for 30 minutes prior to her departure for home. The 30 minute rest interval is not thought to be important. Over the years we have decreased the rest interval from 6 hours to 30 minutes and have experienced increasing pregnancy rates. Following embryo transfer we supplement the ovaries' production of progesterone with injectable progesterone in oil. This is continued for two weeks until a pregnancy test is obtained.
The success rate of the In Vitro Fertilization is highly variable among programs. Also it is now known that the age of the woman is the single most important variable controlling the success rate of IVF. For example, a woman in the twenties will have twice the pregnancy rate of a woman in the forties. The ideal way to analyze results is to look at the clinical pregnancy rate. A clinical pregnancy is one that can be seen with ultrasound. This excludes early or biochemical pregnancies, which are documented by blood testing but never get to the point of being seen with ultrasound. In a good program the pregnancy rate is in the range of 40-50% per egg retrieval. Each year the CDC publishes the data of all reporting clinics. The 2003 data has just been posted on the CDC web site. To view this data directly please use the following link: SART data. Multiple pregnancies are relatively common due to the transfer of more than one embryo. The multiple pregnancy rates will vary between 20-30%. The vast majority of multiple pregnancies are twin pregnancies. A few percent of multiple pregnancies will be triplet or, less commonly, quadruplet pregnancies. Multiple pregnancies are a great concern due to the risk of premature delivery. Prematurely- delivered babies may require assisted respiration and other medical intervention. Of all clinical pregnancies that are generated approximately 20% will be lost to miscarriages. Miscarriages are not any more common with high tech pregnancies than with natural conception. A few percent of all pregnancies generated by IVF will be tubal pregnancies. Over the years IVF has improved and become more predictable and useful as a clinical tool. The ideal candidate for the procedure is still someone with tubal disease where we can achieve our highest pregnancy rate. Many other individuals, however, can succeed with this procedure. The challenge in the future is to continually improve the pregnancy rate. When this occurs, IVF will become the dominant technology because it will be both efficient and simple.
If In Vitro Fertilization results in more embryos than can be transferred, freezing can be used to save the extra embryos. Therefore, in a young woman, if 6 embryos are generated, frequently 2 are transferred and 4 are frozen for future use. If the patient conceives with her fresh embryo transfer, the frozen embryos can later be used to generate a second pregnancy. If the patient does not conceive with the fresh embryo transfer then, after waiting 1 to 2 months, the frozen embryos can be transferred into the uterus to establish an initial pregnancy. The advantage of the availability of the frozen embryos is that frozen embryo transfer is much less costly and time consuming because it does not require a retrieval. One must simply wait one to two days after ovulation and then thaw and transfer the embryos. The pregnancy rate from a frozen embryo transfer is approximately 25%. While this is not as good as the fresh embryo pregnancy rate the amount of effort associated with a frozen embryo transfer is smaller. Embryo cryopreservation has been successful since the mid-80's. The pregnancy rates have continued to improve over the years.
GAMETE INTRAFALLOPIAN TRANSFER (GIFT)
While In Vitro Fertilization came to us from the United Kingdom, GIFT is an American innovation. The first successful case of GIFT was reported by Dr. Ricardo Asch in 1984. GIFT refers to the transfer of gametes "eggs and sperm" into the fallopian tube. Gametes normally meet in the fallopian tube. It was hoped that in some ways that GIFT would be "natural" and would offer improved pregnancy rates. Stimulation protocols for GIFT are identical for IVF. In contradistinction to IVF, GIFT is done by laparoscopy and under a general anesthetic. This is done in order to access both the ovaries and the fallopian tubes. The procedure is done by aspirating all of the follicles in order to retrieve the maximum number of eggs. A plastic tube, "catheter" is then loaded with a certain number of oocytes, which can vary from 4 to 6 as well as 100,000 motile spermatozoa. One or both fallopian tubes are then elevated and cannulated. The sperm and eggs are deposited in the mid-portion of the fallopian tubes. The case is then finished and the eggs and sperm are then allowed to unite in the fallopian tube where natural/normal fertilization occurs. Possible advantages of GIFT include the fact that it is more "natural". However, it is more important to understand that comparing GIFT to IVF is much like comparing apples and oranges. GIFT is more involved due to its requirement for laparoscopy, which is a major surgical procedure. Also, GIFT carries the disadvantage of not allowing us to observe fertilization. Therefore, if a couple does not conceive from GIFT one is uncertain whether this critical process has occurred. It is felt that in the hands of a good embryo laboratory, the results from GIFT and IVF will be fairly similar.
The assisted reproductive technologies are rapidly evolving. Every year there are new discoveries in this area. For instances, we now know that the presence of a hydrosalpinx, which is a tube dilated with fluid, is detrimental to IVF. Today we would remove the hydrosalpinx prior to proceeding with IVF. This was not the case 3 years ago. Also, we have a better understanding of the chemical environment necessary for optimal embryo development and this has been reflected in improvements in the culture media used.
We have also wanted to reduce the number of multiple pregnancies generated. This is now possible through the selection of a fewer number of higher quality embryos for transfer. This technique, called subselection, has improved pregnancy rates and lowered the number of multiple pregnancies generated.
Trying to determine which patient will benefit from IVF and which patient will not do well is very important. This technique is called screening for ovarian reserve. It tells us if the number of high quality eggs is diminished or normal. We can now do this with blood testing. We can check the Day 3 FSH level. We can also do, if necessary, a clomiphene challenge test.
Intracytoplasmic sperm injection (ICSI) has revolutionized IVF. We can today treat successfully cases that were previously impossible to treat. Pregnancies have been established in our program with as few as four sperm identified on the days of the IVF procedure. There are many cases where we simply could not obtain fertilization with standard IVF that are easily treated with ICSI.
The field of assisted reproductive technology has undergone tremendous change since the birth of Mary Louise Brown twenty years ago. The field continues to evolve and indeed we can make the claim that in ART, nothing is constant but change itself! The challenge for us is to use this technology as wisely as possible in each case. We have come a long way in the past two decades and hope to see even more progress in the decades to follow.